scholarly journals Lurasidone‐Induced Tardive Syndrome

2019 ◽  
Vol 6 (7) ◽  
pp. 601-604 ◽  
Author(s):  
Richa Tripathi ◽  
Stephen G. Reich ◽  
Laura Scorr ◽  
Elizabeth Guardiani ◽  
Stewart A. Factor
Keyword(s):  
Tardive Syndrome

scholarly journals Resolution of tardive tremor after bilateral subthalamic nucleus deep brain stimulation placement

2020 ◽  
Vol 11 ◽  
pp. 444
Author(s):  
Samir Kashyap ◽  
Rita Ceponiene ◽  
Paras Savla ◽  
Jacob Bernstein ◽  
Hammad Ghanchi ◽  
...  
Keyword(s):  
Deep Brain Stimulation ◽  
Subthalamic Nucleus ◽  
Brain Stimulation ◽  
Orofacial Dyskinesia ◽  
Major Depressive ◽  
History Of ◽  
Stn Dbs ◽  
Common Manifestation ◽  
Tardive Syndrome ◽  
Deep Brain

Background: Tardive tremor (TT) is an underrecognized manifestation of tardive syndrome (TS). In our experience, TT is a rather common manifestation of TS, especially in a setting of treatment with aripiprazole, and is a frequent cause of referrals for the evaluation of idiopathic Parkinson disease. There are reports of successful treatment of tardive orofacial dyskinesia and dystonia with deep brain stimulation (DBS) using globus pallidus interna (GPi) as the primary target, but the literature on subthalamic nucleus (STN) DBS for tardive dyskinesia (TD) is lacking. To the best of our knowledge, there are no reports on DBS treatment of TT. Case Description: A 75-year-old right-handed female with the medical history of generalized anxiety disorder and major depressive disorder had been treated with thioridazine and citalopram from 1980 till 2010. Around 2008, she developed orolingual dyskinesia. She was started on tetrabenazine in June 2011. She continued to have tremors and developed Parkinsonian gait, both of which worsened overtime. She underwent DBS placement in the left STN in January 2017 with near-complete resolution of her tremors. She underwent right STN implantation in September 2017 with similar improvement in symptoms. Conclusion: While DBS-GPi is the preferred treatment in treating oral TD and dystonia, DBS-STN could be considered a safe and effective target in patients with predominating TT and/or tardive Parkinsonism. This patient saw a marked improvement in her symptoms after implantation of DBS electrodes, without significant relapse or recurrence in the years following implantation.

scholarly journals Tardive syndrome: An update and mini-review from the perspective of phenomenology

2020 ◽  
Vol 83 (12) ◽  
pp. 1059-1065
Author(s):  
Chun-Yu Chen ◽  
Han-Lin Chiang ◽  
Jong-Ling Fuh
Keyword(s):  
Tardive Syndrome

Tardive Syndrome Associated With Tetrabenazine in Huntington Disease

2020 ◽  
Vol 40 (6) ◽  
pp. 628-630
Author(s):  
Giovanni Palermo ◽  
Sonia Mazzucchi ◽  
Elisa Unti ◽  
Ubaldo Bonuccelli ◽  
Roberto Ceravolo
Keyword(s):  
Huntington Disease ◽  
Tardive Syndrome

Antidepressant-induced Tardive Syndrome: a Retrospective Epidemiological Study

2013 ◽  
Vol 46 (07) ◽  
pp. 281-285 ◽  
Author(s):  
Y. Lee ◽  
P.-Y. Lin ◽  
Y.-Y. Chang ◽  
M.-Y. Chong ◽  
A. Cheng
Keyword(s):  
Epidemiological Study ◽  
Tardive Syndrome

Antipsychotics-Induced Tardive Syndrome

2014 ◽  
Vol 37 (4) ◽  
pp. 111-115 ◽  
Author(s):  
Min-Jing Lee ◽  
Pao-Yen Lin ◽  
Yung-Yee Chang ◽  
Mian-Yoon Chong ◽  
Yu Lee
Keyword(s):  
Tardive Syndrome

scholarly journals Abdominal Wall Dyskinesia: Case Report

2020 ◽  
Vol 12 (1) ◽  
pp. 69-72 ◽  
Author(s):  
Leyla Cavdar ◽  
Solomon Ajasin ◽  
Scott Woolf ◽  
Robert Fekete
Keyword(s):  
Case Report ◽  
Abdominal Surgery ◽  
Abdominal Wall ◽  
Dopamine Receptor ◽  
Clinical Presentation ◽  
Anterior Abdominal Wall ◽  
Rare Condition ◽  
Receptor Blocking ◽  
Involuntary Movements ◽  
Tardive Syndrome

The clinical presentation of repetitive choreiform involuntary movements of the anterior abdominal wall was first introduced as “belly dancer’s dyskinesia.” Etiologies of this rare condition include idiopathic causes, medication inducement, or post-abdominal surgery. We report a case of orobuccal stereotypic movements and abdominal wall dyskinesia secondary to prochlorperazine intake. The movements began 2 weeks after cessation of prochlorperazine. The patient took this dopamine receptor-blocking medication for 6 months to treat nausea due to chemotherapy. To our knowledge, abdominal wall dyskinesia as a tardive syndrome of prochlorperazine has not been previously reported.

Aerophagia: A neuroleptic-associated tardive syndrome?

1995 ◽  
Vol 10 (3) ◽  
pp. 235-238 ◽  
Author(s):  
Teruo Hayashi ◽  
Tadashi Nishikawa ◽  
Kazuo Kado ◽  
Itsuyuki Koga ◽  
Yasunori Uchida ◽  
...  
Keyword(s):  
Tardive Syndrome
Sign in / Sign up

Export Citation Format

Share Document